Get notified when MRSH files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NYSE: MRSH MARSH & MCLENNAN COMPANIES, INC. 10-Q

The company recorded a $144 million charge, net of insurance proceeds, related to the Greensill settlement in the third quarter, which is included in operating expenses.

Filed October 15, 2026 · Period ending September 30, 2026 · Compared to 10-Q Oct 16, 2025 · ~1 min read

Key Changes

  • medium

    Consulting revenue grew 8.9% to $2.69B, with operating income up 12.4% to $563.0M.

  • medium

    The company increased its Thrive restructuring program cost estimate from $500 million to approximately $750 million, with expected annualized savings raised to $600 million.

  • medium

    Marsh repurchased 11.4 million shares for $2.0 billion in the first nine months of 2026, and the board authorized a new $6 billion repurchase program in November 2025.

4 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (WS 10-Q) is open in full — no account needed.

Partner

Trade MRSH commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Oct 15, 2026 · How we verify